AA
TECH icon

Ancora Advisors’s Bio-Techne TECH Stock Holding History

Ancora Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$53.9K Buy
1,031
+725
+237% +$43.5K ﹤0.01% 1115
2025
Q4 		$18K Buy
306
+302
+7,550% +$18.4K ﹤0.01% 1597
2025
Q3 		$223 Hold
4
– – ﹤0.01% 1895
2025
Q2 		$206 Buy
+4
New +$201 ﹤0.01% 1895
2025
Q1 		– Sell
-2
Closed -$144 – 1886
2024
Q4 		$144 Buy
+2
New +$147 ﹤0.01% 1756

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ancora Advisors's TECH Position: Q1 2026 in Review

Ancora Advisors increased its Bio-Techne (TECH) stake by 237% in Q1 2026, buying an estimated $43.5K and bringing the position to 1,031 shares worth $53.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1115.

Ancora Advisors first reported a position in TECH in Q4 2024 and has held it in 5 quarters since. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Ancora Advisors held 1,031 shares of Bio-Techne worth $53.9K as of Q1 2026.
  • Ancora Advisors bought 725 Bio-Techne shares in Q1 2026, an estimated $43.5K.
  • Bio-Techne made up ﹤0.01% of Ancora Advisors's portfolio in Q1 2026, its #1115 holding.
  • Ancora Advisors first reported a position in Bio-Techne in Q4 2024 and has held it in 5 quarters since.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.